Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
TScan Therapeutics
TScan Therapeutics develops immunotherapy treatments for cancer.
Sector
Subsector
Location
total rounds
total raised
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing T cell engagers to treat cancer and other diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Ziopharm oncology
ZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.
Sector
Subsector
Keywords
Location
total rounds
total raised
RenBio
RenBio develops antibody-based therapeutic solutions for cancer and inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 11.06.2020. Their latest investor AVICT Global Holdings. Their latest round Series B
Mirae Asset Global Investments
Mirae Asset Global Investments is a global asset manager providing innovative investment solutions.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
CPE
CITIC Private Equity Funds Management is a leading alternative asset manager in China.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
YuanMing Capital
YuanMing Capital is a healthcare specialty fund that focuses on China-US cross-border investments.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors13
Number of lead investors
Number of investors
AVICT Global Holdings
An investment firm.
count Of Investments
Oriza Holdings
Oriza Holdings is a Chinese management fund that has been active in equity, debt financing, and investment since 2007.
Sector
Subsector
Keywords
Location
count Of Investments
Sequoia Capital China
Sequoia Capital China is a venture capital firm that invests in fintech companies at various stages of growth.
Sector
Subsector
Location
count Of Investments
count Of Exists
Acquisitions1
Syracuse Biopharma acquired by JW Therapeutics
acquirer
date
type
Syracuse Biopharma
Syracuse Biopharma commercializes Eureka Therapeutics' TCR-mimic and antibody-TCR ARTEMIS® programs in Asia.
Sector
Subsector
Keywords
Location
People
Founders1
James Li
James Li was the founding General Manager for Amgen in China, where he led the company's efforts in expanding its business into the Chinese market to help Chinese patients gain access to Amgen's vital medicines. Prior to joining Amgen, James was a Partner at Kleiner Perkins Caufield & Byers life science practice, first in the US Pandemic Fund and later, in its China Fund. He successfully invested in early stage university spin out, growth stage companies and led a portfolio company went to public in 2010. From 1991 to 2006, James spent over 15 years with Merck Co. & Inc. where he held leadership positions with increasing responsibilities in clinical research, regulatory affairs, new product development and franchise management, both in the US and Asia Pacific/China. During his tenure, he was instrumental in obtaining regulatory approvals of Merck vaccines across Asia Pacific Region when the Vaccine Division started operations in the region, successfully built the foundations of Merck's medical operations in China and drove the success of Merck's largest franchise in Asia. James received his Medical Degree from Shanghai Medical University followed by a Master of Science degree in Microbiology from the University of Montana.
current job
organization founded
James Li
Employee Profiles3
Che-Hung Yeh
Senior vice president and chief quality officer
Activity
Recent News3
The graph reveals the ratio (%) of positive news articles in a chosen time range